Neuromuscular Disorders

Papers
(The H4-Index of Neuromuscular Disorders is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
P.174 TRIM32 related muscular dystrophy mimicking inflammatory myopathy: Clinical and histopathological features in two siblings127
P137 Prophylactic use of cardiac medications and prolonged survival in Duchenne muscular dystrophy63
P.77 Clinical presentation of two Korean patients with adolescent-onset very-long-chain acyl-CoA dehydrogenase deficiency51
P.53 Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patients47
DMD – ANIMAL MODELS44
P.17 Importance of routine pulmonary check-up prior to ventilatory support in patients with Duchenne muscular dystrophy41
P.30 Correlation of histopathological skeletal muscle biopsy features with quantitative muscle-MRI parameters37
P145 Analysis of the natural evolution of SV95C in ambulant patients with Duchenne muscular dystrophy37
P61 High dose localized muscle irradiation: Hedgehog pathway as a new therapeutic target36
P.224 Non-5q spinal muscular atrophy in twin sisters with SPG11/CMT2X associated spatacsin gene mutation35
P443 A case of Charcot-Marie-Tooth Type 4F34
P33 RKER-065 ameliorated muscle and bone loss in a progressive murine model of Duchenne muscular dystrophy31
P295 Functional improvements by ataluren in dysferlinopathy mice with a compound heterozygous mutations carrying one nonsense variant30
P311 Facioscapulohumeral muscular dystrophy European patient survey: assessing patient preferences in clinical trial participation 28
P304 JOURNEY: a multicenter, longitudinal natural history study of limb girdle muscular dystrophy28
INV09 Novel repeat disorders in muscle disease: the emergence of OPDM27
P154 The generation of a GNE myopathy patient-derived biobank enables the study of disease-relevant cellular phenotypes across multiple pathogenic variants26
P164 Development of a myotube model for C-terminal titin studies25
P251 Vamorolone improves Becker muscular dystrophy and increases dystrophin protein in novel bmx model mice24
SMA - TREATMENT23
SMA - TREATMENT23
WMS General Information22
APPLICATION OF NEXT GENERATION TECHNOLOGIES22
0.078198194503784